The eviQ program has developed a comprehensive suite of product-specific protocols, clinical resources and an education module to support health professionals in safely and effectively delivering bispecific antibody (BsAb) therapies. These resources provide guidance on BsAb mechanisms of action, toxicity profiles and management, and key considerations for patient care.